US Patent 9139583 Selective HDAC3 inhibitors
Patent 9139583 was granted and assigned to Acetylon Pharmaceuticals, Inc. on September, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+158 characters)
Article
Patent abstract
Provided herein are inhibitors of HDAC3, as well as methods of treatment comprising administering those compounds to a subject in need thereof.
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09139583 Selective HDAC3 inhibitors US Patent 9139583 Selective HDAC3 inhibitors
Infobox
Patent Number
0913958300
Patent Number
913958300
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
091395830
Date of Patent
September 22, 2015
0Patent Application Number
141697750
Date Filed
January 31, 2014
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
091395830
Date of Patent
September 22, 2015
0Patent Application Number
141697750
Date Filed
January 31, 2014
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09139583 Selective HDAC3 inhibitors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09139583
Date of patent
September 22, 2015
Patent application number
14169775
Date Filed
January 31, 2014
Patent primary examiner
Find more entities like US Patent 9139583 Selective HDAC3 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
